Department of Cardiovascular Surgery, Tokyo Medical University, Tokyo, Japan -
Department of Cardiovascular Surgery, Tokyo Medical University, Tokyo, Japan.
Int Angiol. 2022 Apr;41(2):136-142. doi: 10.23736/S0392-9590.22.04795-2. Epub 2022 Feb 9.
The purpose of this study was to determine the predictive ability of neutrophilia, lymphocytopenia, and neutrophil-lymphocyte ratio (NLR) for overall mortality after EVAR for AAA.
Data on patients with AAA treated by EVAR between March 2012 and December 2016 were obtained from a prospectively maintained EVAR database at Tokyo Medical University Hospital, Tokyo, Japan. The NLR was calculated by dividing the absolute neutrophil count by the absolute lymphocyte count. A cut-off value of total WBC count, neutrophil count, lymphocyte count, and NLR was determined according to a receiver operating characteristic (ROC) curve. Univariate and multivariate analyses were performed using the Cox proportional hazard analyses to account for the time at risk.
One hundred seventy-eight patients were included in this study after selection based on the exclusion criteria. The subjects consisted of 150 men and 28 women with a mean age of 77.5 years (range: 51-89 years). A ROC curve analysis determined the optimal cut-off values of preoperative total WBC, neutrophils, lymphocytes, and NLR for predicting overall mortality with 7,050 /μL, 4,012 /μL, 1,312 /μL, and 3.19, respectively. On univariate and multivariate analyses, octogenarian, obesity, COPD, active cancer, and lymphocytopenia or NLR were detected as independent predictors for overall mortality.
Specific leukocyte populations, such as lymphocyte count and NLR, are useful biomarkers to predict overall mortality in patients undergoing EVAR for AAA, suggesting that WBC count and its subsets, which are easy to perform a test, may be used to stratify patients at risk for poor prognosis following EVAR.
本研究旨在确定中性粒细胞增多、淋巴细胞减少和中性粒细胞-淋巴细胞比值(NLR)对 EVAR 治疗 AAA 后总死亡率的预测能力。
从日本东京医科大学医院前瞻性维护的 EVAR 数据库中获取 2012 年 3 月至 2016 年 12 月接受 EVAR 治疗的 AAA 患者的数据。NLR 通过将绝对中性粒细胞计数除以绝对淋巴细胞计数来计算。根据受试者工作特征(ROC)曲线确定总白细胞计数、中性粒细胞计数、淋巴细胞计数和 NLR 的截断值。使用 Cox 比例风险分析进行单变量和多变量分析,以考虑风险时间。
根据排除标准对 178 名患者进行选择后,纳入本研究。研究对象包括 150 名男性和 28 名女性,平均年龄为 77.5 岁(范围:51-89 岁)。ROC 曲线分析确定了术前总白细胞计数、中性粒细胞、淋巴细胞和 NLR 预测总死亡率的最佳截断值分别为 7,050 /μL、4,012 /μL、1,312 /μL 和 3.19。单变量和多变量分析显示,80 岁以上、肥胖、COPD、活动性癌症以及淋巴细胞减少或 NLR 是总死亡率的独立预测因子。
特定的白细胞群体,如淋巴细胞计数和 NLR,是预测 EVAR 治疗 AAA 患者总死亡率的有用生物标志物,提示白细胞计数及其亚群,这些易于进行检测,可用于对 EVAR 后预后不良风险的患者进行分层。